After reportedly flirting with going public for years, the artificial intelligence-powered drug developer Insilico Medicine has laid out plans to raise about $292 million through a listing on the ...

Inside a lab at the Massachusetts Institute of Technology late last year, scientists gave an AI system a new task: designing entirely new molecules for potential antibiotics from scratch. Within a day ...

The antibody drug market value is expected to reach $445 billion in the next five years, with over 160 antibodies currently licensed globally for a wide breadth of conditions, including cancer, ...

A promising “two-in-one” experimental drug could tackle both type 2 diabetes and heart disease by slashing cholesterol and inflammation, potentially offering a powerful new way to protect the heart ...

B King became the focus of a murder probe after he and DJ Regio Clown were slain in a turf war over Mexico’s lucrative pink “tusi” drug. B King became the center of a deadly criminal probe after his ...

Photoshop CS6 tutorial showing how to create a gorgeous swimming pool with a custom-made mosaic-tiled floor adorned with your own images and your own text. The final image also has filtered sun rays ...

An MIT team used artificial intelligence to design novel antibiotics, two of which showed promise against MRSA and gonorrhea. With help from artificial intelligence, MIT researchers have designed ...

Dianthus Therapeutics and Boehringer Ingelheim headlined the latest round of licensing deals featuring Chinese biotechs. Fierce's deep dive into the dispute between Novo Nordisk and KBP Biosciences ...

Oct 14 (Reuters) - U.S. biotech firm Nabla Bio said on Tuesday it has signed a second major research partnership with Japanese drugmaker Takeda Pharmaceutical (4502.T), opens new tab, deepening their ...

After walking away from cell therapy and narrowing its focus to just three modalities, Takeda is doubling down on its remaining strategic commitment by reupping a pact with AI drug designer Nabla Bio.

HONOLULU (HawaiiNewsNow) - A dangerous combination of bromazolam and fentanyl is fueling a sharp rise in overdose deaths across Oahu. The drug, often called fake Xanax or designer Xanax, is being ...

Researchers at Harvard Medical School developed a tool that uses artificial intelligence to accelerate drug discovery and development. The new technology, called PDGrapher, applies machine learning to ...